Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP8JR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $108,372
Award facts
- Contract value 100% obligated
- $108,372.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $108,372.26 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens, with an ultimate completion date of January 6, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which serves as the place of performance—is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026, which serves as the parent contract vehicle enabling this delivery order.
This delivery order falls under AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which provides a broad range of medications and medical supplies to support Department of Defense healthcare programs globally. The Dupixent product supplied through this order is a specialty pharmaceutical used in the treatment of atopic dermatitis and other inflammatory conditions, reflecting the vendor's portfolio of specialized medical products serving military and federal healthcare systems. The firm fixed-price structure and competitive award process demonstrate AmerisourceBergen Drug Corp's established capability to meet federal procurement requirements for pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FP8JR?
SPE2DR26FP8JR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FP8JR worth?
The government has obligated $108,372 on SPE2DR26FP8JR.
Is contract SPE2DR26FP8JR an order under another contract?
Yes. SPE2DR26FP8JR is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8JR competed?
The extent of competition for SPE2DR26FP8JR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award